Deutsche Bank lowered the firm’s price target on Bio-Techne to $70 from $100 and keeps a Buy rating on the shares following the fiscal Q1 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TECH:
